BR0005633A - Derivados de quinolina úteis para inibição da farnesil proteìna transferase - Google Patents
Derivados de quinolina úteis para inibição da farnesil proteìna transferaseInfo
- Publication number
- BR0005633A BR0005633A BR0005633-2A BR0005633A BR0005633A BR 0005633 A BR0005633 A BR 0005633A BR 0005633 A BR0005633 A BR 0005633A BR 0005633 A BR0005633 A BR 0005633A
- Authority
- BR
- Brazil
- Prior art keywords
- protein transferase
- farnesyl protein
- compounds
- derivatives useful
- quinoline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Patente de Invenção: <B>"DERIVADOS DE QUINOLINA úTEIS PARA INIBIçãO DA FARNESIL PROTEìNA TRANSFERASE"<D>. A invenção refere-se a compostos da fórmula: e a sais farmaceuticamente aceitáveis derivados e solvatos resultantes em que Y, R¹, R², R³, R^ 4^, R^ 5^, R^ 6^, R^ 7^, R^ 8^, R^ 9^, e R^ 10^ têm os significados definidos na especificação. A invenção também refere-se a composições farmacêuticas compreendendo os ditos compostos e ao uso dos ditos compostos para inibição do crescimento celular anormal em mamíferos. Os compostos da forma acima descrita têm atividade como inibidores da farnesil proteína transferase.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16820799P | 1999-11-30 | 1999-11-30 | |
US17011999P | 1999-12-10 | 1999-12-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0005633A true BR0005633A (pt) | 2001-07-17 |
Family
ID=26863889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0005633-2A BR0005633A (pt) | 1999-11-30 | 2000-11-30 | Derivados de quinolina úteis para inibição da farnesil proteìna transferase |
Country Status (12)
Country | Link |
---|---|
US (1) | US6596735B1 (pt) |
EP (1) | EP1106612B1 (pt) |
JP (1) | JP2001213876A (pt) |
AT (1) | ATE259365T1 (pt) |
BR (1) | BR0005633A (pt) |
CA (1) | CA2327026A1 (pt) |
DE (1) | DE60008206T2 (pt) |
DK (1) | DK1106612T3 (pt) |
ES (1) | ES2212971T3 (pt) |
MX (1) | MXPA00011856A (pt) |
PT (1) | PT1106612E (pt) |
TR (1) | TR200400342T4 (pt) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11209350A (ja) * | 1998-01-26 | 1999-08-03 | Eisai Co Ltd | 含窒素複素環誘導体およびその医薬 |
DE60118225T2 (de) * | 2000-09-25 | 2007-05-03 | Janssen Pharmaceutica N.V. | Chinolin- und chinazolinderivate und deren verwendung als farnesyl transferase inhibitoren |
US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
EP1585743B1 (en) | 2002-12-19 | 2007-05-23 | Pfizer Inc. | 2-(1h-indazol-6-ylamino)- benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases |
JP4691041B2 (ja) | 2003-11-20 | 2011-06-01 | チルドレンズ ホスピタル メディカル センター | Gtpアーゼ阻害剤および使用方法 |
AU2004298486A1 (en) | 2003-12-12 | 2005-06-30 | Wyeth | Quinolines useful in treating cardiovascular disease |
BRPI0509580A (pt) * | 2004-03-30 | 2007-11-27 | Pfizer Prod Inc | combinações de inibidores de transdução de sinal |
EP1786785B9 (en) * | 2004-08-26 | 2013-05-22 | Pfizer Inc. | Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors |
WO2006021881A2 (en) * | 2004-08-26 | 2006-03-02 | Pfizer Inc. | Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |
EP1786777A1 (en) * | 2004-08-26 | 2007-05-23 | Pfizer, Inc. | Aminoheteroaryl compounds as protein tyrosine kinase inhibitors |
US20060107555A1 (en) * | 2004-11-09 | 2006-05-25 | Curtis Marc D | Universal snow plow adapter |
WO2007016539A2 (en) | 2005-07-29 | 2007-02-08 | Children's Hospital Medical Center | Gtpase inhibitors and methods of use and crystal structure of rac-1 gtpase |
CA2621371C (en) * | 2005-09-07 | 2018-05-15 | Amgen Fremont Inc. | Human monoclonal antibodies to activin receptor-like kinase-1 |
ES2374450T3 (es) | 2005-09-20 | 2012-02-16 | OSI Pharmaceuticals, LLC | Marcadores biológicos predictivos de respuesta anticancerígena para inhibidores de cinasa del receptor del factor de crecimiento 1 similar a insulina. |
TW200812615A (en) | 2006-03-22 | 2008-03-16 | Hoffmann La Roche | Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2 |
DK2056874T3 (da) | 2006-08-21 | 2012-10-15 | Hoffmann La Roche | Tumorterapi med et anti-vegf-antistof |
WO2009151910A2 (en) * | 2008-05-25 | 2009-12-17 | Wyeth | Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer |
US20120189641A1 (en) | 2009-02-25 | 2012-07-26 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
US20110171124A1 (en) | 2009-02-26 | 2011-07-14 | Osi Pharmaceuticals, Inc. | In situ methods for monitoring the EMT status of tumor cells in vivo |
US8465912B2 (en) | 2009-02-27 | 2013-06-18 | OSI Pharmaceuticals, LLC | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
WO2010099138A2 (en) | 2009-02-27 | 2010-09-02 | Osi Pharmaceuticals, Inc. | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
WO2010099363A1 (en) | 2009-02-27 | 2010-09-02 | Osi Pharmaceuticals, Inc. | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
WO2011093365A1 (ja) * | 2010-01-27 | 2011-08-04 | 協和発酵キリン株式会社 | 含窒素複素環化合物 |
CA2783656A1 (en) | 2010-03-03 | 2011-09-09 | OSI Pharmaceuticals, LLC | Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
EP2542893A2 (en) | 2010-03-03 | 2013-01-09 | OSI Pharmaceuticals, LLC | Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
WO2012116040A1 (en) | 2011-02-22 | 2012-08-30 | OSI Pharmaceuticals, LLC | Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors in hepatocellular carcinoma |
WO2012149014A1 (en) | 2011-04-25 | 2012-11-01 | OSI Pharmaceuticals, LLC | Use of emt gene signatures in cancer drug discovery, diagnostics, and treatment |
WO2013152252A1 (en) | 2012-04-06 | 2013-10-10 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
WO2013166043A1 (en) | 2012-05-02 | 2013-11-07 | Children's Hospital Medical Center | Rejuvenation of precursor cells |
EP2909189B8 (en) | 2012-10-16 | 2017-04-19 | Janssen Pharmaceutica NV | Heteroaryl linked quinolinyl modulators of ror-gamma-t |
WO2014062658A1 (en) | 2012-10-16 | 2014-04-24 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of ror-gamma-t |
EP2909193B1 (en) | 2012-10-16 | 2017-04-19 | Janssen Pharmaceutica NV | Phenyl linked quinolinyl modulators of ror-gamma-t |
AR094403A1 (es) | 2013-01-11 | 2015-07-29 | Hoffmann La Roche | Terapia de combinación de anticuerpos anti-her3 |
AU2014334616A1 (en) | 2013-10-15 | 2016-04-28 | Janssen Pharmaceutica Nv | Quinolinyl modulators of RORyt |
US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
US9346782B2 (en) | 2013-10-15 | 2016-05-24 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
US10028503B2 (en) | 2014-06-18 | 2018-07-24 | Children's Hospital Medical Center | Platelet storage methods and compositions for same |
MX2018006781A (es) | 2015-12-03 | 2018-11-09 | Agios Pharmaceuticals Inc | Inhibidores de mat2a para el tratamiento del cancer que no expresen mtap. |
WO2021155006A1 (en) | 2020-01-31 | 2021-08-05 | Les Laboratoires Servier Sas | Inhibitors of cyclin-dependent kinases and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW349948B (en) * | 1995-10-31 | 1999-01-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 2-quinolone derivatives |
ATE321757T1 (de) * | 1995-12-08 | 2006-04-15 | Janssen Pharmaceutica Nv | (imidazol-5-yl)methyl-2-chinolinonderivate als farnesyl protein transferase inhibitoren |
TW591030B (en) * | 1997-03-10 | 2004-06-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles |
CN1231215C (zh) * | 1997-06-02 | 2005-12-14 | 詹森药业有限公司 | (咪唑-5-基)甲基-2-喹啉酮衍生物用作平滑肌细胞增殖抑制剂 |
EA003510B1 (ru) * | 1998-07-06 | 2003-06-26 | Янссен Фармацевтика Н.В. | Ингибиторы фарнезилпротеинтрансферазы, применяемые для лечения артропатий |
PL349839A1 (en) * | 1999-02-11 | 2002-09-23 | Pfizer Prod Inc | Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
-
2000
- 2000-11-01 ES ES00309627T patent/ES2212971T3/es not_active Expired - Lifetime
- 2000-11-01 PT PT00309627T patent/PT1106612E/pt unknown
- 2000-11-01 TR TR2004/00342T patent/TR200400342T4/xx unknown
- 2000-11-01 DE DE60008206T patent/DE60008206T2/de not_active Expired - Fee Related
- 2000-11-01 EP EP00309627A patent/EP1106612B1/en not_active Expired - Lifetime
- 2000-11-01 AT AT00309627T patent/ATE259365T1/de not_active IP Right Cessation
- 2000-11-01 DK DK00309627T patent/DK1106612T3/da active
- 2000-11-28 US US09/724,464 patent/US6596735B1/en not_active Expired - Fee Related
- 2000-11-28 CA CA002327026A patent/CA2327026A1/en not_active Abandoned
- 2000-11-29 JP JP2000362840A patent/JP2001213876A/ja not_active Withdrawn
- 2000-11-30 MX MXPA00011856A patent/MXPA00011856A/es active IP Right Grant
- 2000-11-30 BR BR0005633-2A patent/BR0005633A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2001213876A (ja) | 2001-08-07 |
EP1106612A1 (en) | 2001-06-13 |
ES2212971T3 (es) | 2004-08-16 |
ATE259365T1 (de) | 2004-02-15 |
US6596735B1 (en) | 2003-07-22 |
EP1106612B1 (en) | 2004-02-11 |
CA2327026A1 (en) | 2001-05-30 |
DK1106612T3 (da) | 2004-05-17 |
PT1106612E (pt) | 2004-06-30 |
DE60008206D1 (de) | 2004-03-18 |
MXPA00011856A (es) | 2002-06-04 |
TR200400342T4 (tr) | 2004-03-22 |
DE60008206T2 (de) | 2004-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0005633A (pt) | Derivados de quinolina úteis para inibição da farnesil proteìna transferase | |
BR9916980A (pt) | Derivados bicìclicos substituìdos úteis como agentes anticancerìgenos | |
ATE242231T1 (de) | Carbonyl-piperaznyl und piperidinyl derivate zur hemmung farnesyl protein transferase | |
PT1029853E (pt) | Derivados biciclicos heteroaromaticos uteis como agentes anticancerigenos | |
BR0008202A (pt) | Derivados de quinolin-2-ona substituìdos com heteroarilas úteis como agentes contra o câncer | |
EA200300248A1 (ru) | Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции | |
ATE260255T1 (de) | 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate | |
HUP0101146A2 (hu) | Foszfolipáz enzim inhibitor hatású indolszármazékok, valamint a vegyületeket tartalmazó gyógyászati készítmények | |
TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
EA200500174A1 (ru) | Новые производные бензимидазола, полезные в качестве антипролиферативных агентов | |
BR9908545A (pt) | Derivado de piperidina, processo para a preparação do mesmo, composto, processo para a preparação do mesmo, e, composição farmacêutica | |
ATE321038T1 (de) | Chinolin- und chinazolinderivate und deren verwendung als farnesyl transferase inhibitoren | |
ES2191260T3 (es) | Derivados de la imidazolidin-4-ona utiles como agentes anticancerosos. | |
AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
PT992509E (pt) | Novos derivados macrolidos | |
DE69008142D1 (de) | 4-Substituierten Imidazolen zur Senkung des intraokularen Druckes. | |
DK1165544T3 (da) | Substituerede 1,4-dihydroindeno[1,2-c]pyrazoler som inhibitorer af tyrosinkinase | |
YU49902A (sh) | Supstituisani derivati piperazina kao mtp inhibitori | |
NO983444L (no) | Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer | |
ATE219085T1 (de) | 2-beta-substituierte-6-alkylidenpenizillansäure derivate als beta-laktamase inhibitoren | |
PT1351954E (pt) | Derivados 4-heterociclil-quinolina e quinazolina inibidores da farnesil-transferase | |
HRP990130B1 (en) | HALOGEN DERIVATIVES 9a-N-(N'-ARYLCARBAMOYL)- AND 9a-N-(N'-ARYLTHIOCARBAMOYL)-9-DEOXO-9a-AZA-9a OF HOMOERYTHROMYCIN A | |
DE69908855D1 (de) | 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009. |